This inventor holds 4 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignee: Biovie Inc.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: Penelope Markham: Innovator in Pharmaceutical Compositions
Introduction
Penelope Markham is a distinguished inventor based in Clifton, VA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations involving terlipressin. With a total of 4 patents to her name, her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Markham's latest patents include innovative pharmaceutical compositions that comprise terlipressin with increased concentration and long-term storage stability. Additionally, she has developed a method for treating patients with ascites by administering terlipressin through continuous infusion. This method is particularly beneficial for patients whose ascites condition has not progressed to hepatorenal syndrome (HRS), and it can be administered using a continuous infusion pump.
Career Highlights
Throughout her career, Markham has demonstrated a commitment to advancing medical treatments through her innovative research. Her work at Biovie Inc. has positioned her as a key player in the pharmaceutical industry, where she continues to explore new avenues for improving patient care.
Collaborations
Markham collaborates with notable colleagues, including Jonathan Adams and Paolo Angeli, who contribute to her research efforts and enhance the impact of her work.
Conclusion
In summary, Penelope Markham is a pioneering inventor whose contributions to pharmaceutical compositions are noteworthy. Her innovative approaches to treating ascites and enhancing terlipressin formulations reflect her dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile